Emerging trends in sacubitril/valsartan research: A bibliometric analysis of the years 1995–2021

BACKGROUND: Sacubitril/valsartan has been approved for the treatment of heart failure (HF) patients with reduced ejection fraction; since then, it gradually became a new star drug in the therapy of HF. Nevertheless, the effectiveness of sacubitril/valsartan remains under investigation. Thus far, onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lai, Ping, Xue, Jin-Hua, Xie, Mu-Jin, Ye, Jin-Hua, Tian, Ke-Jun, Ling, Jia-Yuan, Zhong, Wen-Ting, Chen, Dong, Zhong, Yi-Ming, Liao, Yong-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351920/
https://www.ncbi.nlm.nih.gov/pubmed/35945796
http://dx.doi.org/10.1097/MD.0000000000029398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351920/
https://www.ncbi.nlm.nih.gov/pubmed/35945796
http://dx.doi.org/10.1097/MD.0000000000029398

Ejemplares similares